A Cohort Study of Drug Users' Compliance With Zidovudine Treatment
Archives of Internal MedicinePublished 23 May 1994
Barbara Broers
Citations142
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Injecting drug users tend to delay the start of zidovudine treatment, but once they have started, their compliance is no worse than the compliance of patients from other risk groups, which has important implications for clinical trials, medical care, and public health.
Abstract
Injecting drug users tend to delay the start of zidovudine treatment. However, once they have started, their compliance is no worse than the compliance of patients from other risk groups. These results have important implications for clinical trials, medical care, and public health.
Keywords
Medicine
Annals of Internal MedicineUnderstanding and Improving Patient Compliance
794 Citations1984Stephen A. Eraker, JOHN P. KIRSCHT +1 more
The problem of patient compliance, as well as the ability of the physician to understand, detect, and improve compliance are described in relation to a new model of health decisions and patient behavior.
American Review of Respiratory DiseaseResurgent Tuberculosis in New York City: Human Immunodeficiency Virus, Homelessness, and the Decline of Tuberculosis Control Programs
655 Citations1991Karen Brudney, Jay F. Dobkin
New England Journal of MedicineClinical Manifestations and Predictors of Disease Progression in Drug Users with Human Immunodeficiency Virus Infection
286 Citations1992Peter A. Selwyn, Philip Alcabes +6 more
HIV-infected injection-drug users have progression to AIDS at rates comparable to those of other HIV- infected groups, but they have substantial pre-AIDS morbidity and mortality, particularly from bacterial infections, which also appear to predict disease progression.
The American Journal of MedicineCompliance with zidovudine therapy in patients infected with human immunodeficiency virus, type 1: A cross-sectional study in a municipal hospital clinic
225 Citations1992Jeffrey H. Samet, Howard Libman +8 more
High compliance with zidovudine was achieved by HIV-infected patients in a municipal hospital clinic, many of whom had a history of intravenous drug use and may be enhanced by a patient's belief that it prolongs life and the use of a medication timer for proper dosing.
JAMAPrimary Care Physicians and AIDS
198 Citations1991Barbara Gerbert
The data suggest that many primary care physicians are responding professionally to the AIDS epidemic but that attitudinal barriers may be hindering some physicians from providing treatment to HIV-infected patients.
AIDSInternational epidemiology of HIV and AIDS among injecting drug users
179 Citations1992Don C. Des Jarlais, Samuel R. Friedman +3 more
The variation in HIV seroprevalence among IVD users, rapid HIV spread among users, HIV amongIVDUs in Bangkok, emerging issues in HIV transmission among IVdUs, non-AIDS manifestations of HIV infection among IV DUs, prevention programs and effectiveness, and harm reduction are examined.
JAMAThe Challenge of Minority Recruitment in Clinical Trials for AIDS
152 Citations1992Wafaa El‐Sadr
A number of studies have shown differences between African Americans and whites in response to antihypertensive therapy, and these studies suggest that race is an important consideration when planning and planning for clinical trials.
Journal of General Internal MedicineDifferences in access to zidovudine (AZT) among symptomatic HIV-infected persons
141 Citations1991Michael D. Stein, John D. Piette +5 more
Archives of Internal MedicineHuman immunodeficiency virus infection among homeless men in a New York City shelter. Association with Mycobacterium tuberculosis infection
109 Citations1990Ramón A. Torres
JAMARacial and Ethnic Differences in Outcome in Zidovudine-Treated Patients With Advanced HIV Disease
93 Citations1991Philippa Easterbrook
Racial differences in survival and the development of opportunistic infections are mainly due to the more advanced HIV disease in black patients when zidovudine therapy is started and to their less frequent use of PCP prophylaxis.
The American Journal of MedicineHuman immunodeficiency virus infection in intravenous drug users: A model for primary care
79 Citations1992Patrick G. O’Connor, Susan Molde +3 more
By offering primary care services with drug treatment, the CMU model may be an effective way of providing access to primary care for HIV-infected IVDUs and for facilitating compliance.
Annals of Internal MedicinePrimary Care for Patients with Human Immunodeficiency Virus (HIV) Infection in a Methadone Maintenance Treatment Program
78 Citations1989Peter A. Selwyn, Anat R. Feingold +5 more
Intravenous drug users account for a growing number and percentage of cases of the acquired immunodeficiency syndrome (AIDS) in the United States, and as hospitals become further burdened by the rising number of cases, the need for awareness and education about the risks and benefits of using these drugs is increasing.
PubMedNational AIDS incidence trends and the extent of zidovudine therapy in selected demographic and transmission groups.
61 Citations1991Rosenberg Ps, Mh Gail +8 more
Available data suggest that zidovudine, perhaps in combination with other therapies, has been one factor contributing to favorable AIDS incidence trends in some groups, especially in intravenous drug users, persons infected through heterosexual contact, minorities, women, and persons diagnosed outside major metropolitan areas.
JAMAEffects of Zidovudine Therapy in Minority and Other Subpopulations With Early HIV Infection
53 Citations1991Stephen W. Lagakos
The data suggest that the beneficial effects of zidovudine reported for the entire study population also apply to the subpopulations of blacks, Hispanics, women, and intravenous drug users.
Annals of Internal MedicineTreatment for Cerebral Toxoplasmosis Protects against <i>Pneumocystis carinii</i> Pneumonia in Patients with AIDS
37 Citations1991Alison Heald, Markus Flepp +7 more
Patients with cerebral toxoplasmosis have a low risk for subsequently developing P. carinii pneumonia and this decreased risk is probably the result of chronic suppressive treatment with pyrimethamine and sulfonamides.
PubMedZidovudine therapy in an inner city population.
30 Citations1990Jonathan E. Samuels, Josephine Hendrix +4 more
It is concluded that zidovudine can be administered to intravenous drug users and others in an inner city clinic with acceptable compliance and tolerance.
BiometricsEstimating Compliance to Study Medication from Serum Drug Levels: Application to an AIDS Clinical Trial of Zidovudine
27 Citations1992L. Lim
This paper examines the use of serum drug levels to assess compliance to study medication in a clinical trial of zidovudine and describes a method that uses the accessory data to provide the additional information needed for computing the compliance estimate.
DICPMedication Usage Patterns in Patients with Human Immunodeficiency Virus Infection: A Comparison of Patient-Reported Medication Usage with Medical Chart Review
16 Citations1991Abraham G. Hartzema, Miquel S. Porta +6 more
PubMedAIDS in intravenous drug users: issues related to enrollment in clinical trials.
15 Citations1990Craven De, Liebman Ha +6 more
There is no area in which there is so much mystery, so much misunderstanding and so many differences of opinion as the area of narcotics.
PubMedPsychosocial issues in symptomatic HIV infection.
10 Citations1991Richard Sadovsky
The patient must be given the opportunity to be an active participant in decisions about treatment and lifestyle, and good communication and a multidisciplinary team approach are essential aspects of successful management.
Archives of Internal MedicineObservations Concerning the Use of Zidovudine in an Outpatient Setting
1 Citations1991William Paul Skelton
This work analyzed 28 charts of patients receiving zidovudine to determine if proper indications for commencement of therapy were present, recommended dosage followed, toxicity discovered, length of time between visits was appropriate, and whether patients were compliant.
PubMed[Epidemiology of HIV infections in Switzerland and the German Federal Republic--contribution of official surveillance systems, of anonymous testing and of blood donor screening].
1 Citations1992Josef Estermann, Sulliger Jm +1 more
Data suggest that the overall prevalence is higher in Switzerland than in the Federal Republic of Germany, and data on blood donations and anonymous testing collected in Switzerland, are helpful in estimating trends and prevalence in the general population.